Finance

Lists
HRTIS:HEL
Herantis Pharma Oyj
€1.60
+2.31%
(+0.036) 1D
Sep 4, 6:00:00 PM GMT+3  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HRTIS...
Open
€1.56
High
€1.60
Low
€1.55
Mkt. cap
42.35M
Avg. vol.
32.95K
Volume
6.90K
52-wk high
€3.87
52-wk low
€1.44
EPS
-€0.28
Shares outstanding
26.50M
No. of employees
14
Open
€1.56
High
€1.60
Low
€1.55
Mkt. cap
42.35M
Avg. vol.
32.95K
Volume
6.90K
52-wk high
€3.87
52-wk low
€1.44
EPS
-€0.28
Shares outstanding
26.50M
No. of employees
14
About Herantis Pharma Oyj
CEOAntti Vuolanto
Employees14
Founded2008
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402.99K
402.99K
585.00K
585.00K
Operating expense
1.72M
1.72M
1.53M
1.53M
Total operating expenses
1.72M
1.72M
1.53M
1.53M
Operating income
-1.72M
-1.72M
-1.53M
-1.53M
Other non operating income
-150.07K
-150.07K
15.00K
15.00K
EBT including unusual items
-1.71M
-1.71M
-1.66M
-1.66M
EBT excluding unusual items
-1.71M
-1.71M
-1.66M
-1.66M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
1.32M
1.32M
946.50K
946.50K
Net income
-1.71M
-1.71M
-1.66M
-1.66M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
160.84K
160.84K
3.50K
3.50K
Interest expense
-
-
-149.00K
-149.00K
Net interest expenses
160.84K
160.84K
-145.50K
-145.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps